Oliveri A

References (3)

Title : LYPLAL1 Rare Loss-of-Function Variants in Humans and Deletion in Human Hepatoma Cells Protect Against MASLD - Hussain_2026_J.Lipid.Res__101013
Author(s) : Hussain R , Raut C , Prabhu P , Irshaid A , Hegde Y , Chen Y , Pant A , Oliveri A , Wei X , Yin L , Russell TL , Halligan B , Semenkovich CF , Speliotes EK
Ref : J Lipid Res , :101013 , 2026
Abstract :
PubMedSearch : Hussain_2026_J.Lipid.Res__101013
PubMedID: 41786251
Gene_locus related to this paper: human-LYPLAL1

Title : Human genetics of metabolic dysfunction-associated steatotic liver disease: from variants to cause to precision treatment - Chen_2025_J.Clin.Invest_135_
Author(s) : Chen VL , Kuppa A , Oliveri A , Chen Y , Ponnandy P , Patel PB , Palmer ND , Speliotes EK
Ref : J Clinical Investigation , 135 : , 2025
Abstract :
PubMedSearch : Chen_2025_J.Clin.Invest_135_
PubMedID: 40166930

Title : A Very Low-Carbohydrate Program in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease and Phospholipase Domain-Containing Protein 3 Risk Genotype: Pre-Post Intervention Study - Saslow_2025_JMIR.Form.Res_9_e60051
Author(s) : Saslow LR , Krinock J , O'Brien A , Raymond K , Bayandorian H , Moskowitz JT , Daubenmier J , Oliveri A , Marriott DJ , Griauzde DH , Speliotes EK
Ref : JMIR Form Res , 9 :e60051 , 2025
Abstract :
PubMedSearch : Saslow_2025_JMIR.Form.Res_9_e60051
PubMedID: 39801107